These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16498444)

  • 1. ASPP [corrected] and cancer.
    Trigiante G; Lu X
    Nat Rev Cancer; 2006 Mar; 6(3):217-26. PubMed ID: 16498444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53: an overview of over two decades of study.
    Cheah PL; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):9-16. PubMed ID: 16329542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53.
    Gillotin S; Lu X
    FEBS Lett; 2011 Jun; 585(12):1778-82. PubMed ID: 21513714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complicating the complexity of p53.
    Yee KS; Vousden KH
    Carcinogenesis; 2005 Aug; 26(8):1317-22. PubMed ID: 15888490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins.
    Skene-Arnold TD; Luu HA; Uhrig RG; De Wever V; Nimick M; Maynes J; Fong A; James MN; Trinkle-Mulcahy L; Moorhead GB; Holmes CF
    Biochem J; 2013 Feb; 449(3):649-59. PubMed ID: 23088536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of p53 activation--spoilt for choice.
    Vousden KH
    J Cell Sci; 2006 Dec; 119(Pt 24):5015-20. PubMed ID: 17158908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 alterations in human cancer: more questions than answers.
    Soussi T
    Oncogene; 2007 Apr; 26(15):2145-56. PubMed ID: 17401423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
    Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
    Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways.
    Shibue T; Suzuki S; Okamoto H; Yoshida H; Ohba Y; Takaoka A; Taniguchi T
    EMBO J; 2006 Oct; 25(20):4952-62. PubMed ID: 17024184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel isoform of iASPP and its interaction with p53.
    Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
    J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
    Selivanova G; Wiman KG
    Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with p53, dying of p53.
    Aylon Y; Oren M
    Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp70 interactions with the p53 tumour suppressor protein.
    Zylicz M; King FW; Wawrzynow A
    EMBO J; 2001 Sep; 20(17):4634-8. PubMed ID: 11532927
    [No Abstract]   [Full Text] [Related]  

  • 20. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
    Liu Z; Liu Q; Xu B; Wu J; Guo C; Zhu F; Yang Q; Gao G; Gong Y; Shao C
    Mutat Res; 2009 Mar; 662(1-2):75-83. PubMed ID: 19159633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.